Kang Soo Jung, Kim Nam Su
Department of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine, CHA University, Seongnam, Korea.
Department of Pediatrics, Hanyang University Hospital, Hanyang University College of Medicine, Seoul, Korea.
Korean J Pediatr. 2017 Jul;60(7):208-215. doi: 10.3345/kjp.2017.60.7.208. Epub 2017 Jul 31.
Activation of Toll-like receptor 2 (TLR2) present on circulating monocytes in patients with Kawasaki disease (KD) can lead to the production of proinflammatory cytokines and interleukin-10 (IL-10). We aimed to determine the association of the frequency of circulating TLR2+/CD14+ monocytes (FTLR2%) with the outcomes of KD, as well as to compare FTLR2% to the usefulness of sIL-10.
The FTLR2% in patients with KD was measured by flow cytometry. Serum levels of IL-10 (sIL-10) were determined in 31 patients with KD before the initial treatment with intravenous immunoglobulin (IVIG) and in 21 febrile controls by using enzyme-linked immunosorbent assay. Patients were classified as having coronary artery lesions (CALs) based on the maximal internal diameters of the proximal right coronary artery and proximal left anterior descending coronary artery one month after the initial diagnosis.
We found that FTLR2% greater than 92.62% predicted CALs with 80% sensitivity and 68.4% specificity, whereas FTLR2% more than 94.61% predicted IVIG resistance with 66.7% sensitivity and 71.4% specificity. Moreover, sIL-10 more than 15.52 pg/mL predicted CALs and IVIG resistance with 40% and 66.7% sensitivity, respectively, and 73.7% and 76.2% specificity, respectively.
We showed that measuring FTLR2% before the initial treatment could be useful in predicting CAL development with better sensitivity than sIL-10 and with results comparable to sIL-10 results for the prediction of IVIG resistance in patients with KD. However, further studies are necessary to validate FTLR2% as a marker of prognosis and severity of KD.
川崎病(KD)患者循环单核细胞上存在的Toll样受体2(TLR2)的激活可导致促炎细胞因子和白细胞介素-10(IL-10)的产生。我们旨在确定循环TLR2+/CD14+单核细胞频率(FTLR2%)与KD结局之间的关联,并将FTLR2%与可溶性IL-10(sIL-10)的效用进行比较。
通过流式细胞术测量KD患者的FTLR2%。采用酶联免疫吸附测定法,在31例初次接受静脉注射免疫球蛋白(IVIG)治疗前的KD患者和21例发热对照者中测定血清IL-10(sIL-10)水平。根据初次诊断后1个月时右冠状动脉近端和左前降支冠状动脉近端的最大内径,将患者分类为患有冠状动脉病变(CALs)。
我们发现,FTLR2%大于92.62%预测CALs的敏感性为80%,特异性为68.4%,而FTLR2%大于94.61%预测IVIG抵抗的敏感性为66.7%,特异性为71.4%。此外,sIL-10大于15.52 pg/mL预测CALs和IVIG抵抗的敏感性分别为40%和66.7%,特异性分别为73.7%和76.2%。
我们表明,在初次治疗前测量FTLR2%有助于预测CAL的发生,其敏感性优于sIL-10,且预测KD患者IVIG抵抗的结果与sIL-10相当。然而,需要进一步研究来验证FTLR2%作为KD预后和严重程度标志物的作用。